Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Drug Substance Manufacturing
  6.  » mRNA: A New Option for Vaccines and Therapeutics

mRNA: A New Option for Vaccines and Therapeutics

Summary: Breaking New Ground: Turning mRNA into an Established Therapeutic Modality (Video 1 of 3 in the mRNA fireside chat series with Catalent’s experts). Once one of the riskiest new technologies in drug R&D, the pandemic made mRNA a household word, with BioNTech and Moderna driving quickly to global regulatory approvals for their blockbuster vaccines. mRNA has gained tremendous attention in recent years. In addition to COVID-19, among the RNA-based therapeutics, mRNA have the potential to treat a variety of diseases.